JP2010526025A5 - - Google Patents

Download PDF

Info

Publication number
JP2010526025A5
JP2010526025A5 JP2009546409A JP2009546409A JP2010526025A5 JP 2010526025 A5 JP2010526025 A5 JP 2010526025A5 JP 2009546409 A JP2009546409 A JP 2009546409A JP 2009546409 A JP2009546409 A JP 2009546409A JP 2010526025 A5 JP2010526025 A5 JP 2010526025A5
Authority
JP
Japan
Prior art keywords
bis
trifluoromethyl
propyl
hydrazinecarboxamide
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009546409A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010526025A (ja
Filing date
Publication date
Priority claimed from US11/653,972 external-priority patent/US7994221B2/en
Application filed filed Critical
Publication of JP2010526025A publication Critical patent/JP2010526025A/ja
Publication of JP2010526025A5 publication Critical patent/JP2010526025A5/ja
Pending legal-status Critical Current

Links

JP2009546409A 2007-01-17 2008-01-16 スルホニルセミカルバジド、カルボニルセミカルバジド、セミカルバジドおよび尿素、その薬学的組成物、ならびにアレナウイルスに関連する感染を含む、出血熱ウイルスを治療するための方法。 Pending JP2010526025A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/653,972 US7994221B2 (en) 2004-12-06 2007-01-17 Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
PCT/US2008/000529 WO2008147474A2 (en) 2007-01-17 2008-01-16 Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses

Publications (2)

Publication Number Publication Date
JP2010526025A JP2010526025A (ja) 2010-07-29
JP2010526025A5 true JP2010526025A5 (cg-RX-API-DMAC7.html) 2011-03-10

Family

ID=40075707

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009546409A Pending JP2010526025A (ja) 2007-01-17 2008-01-16 スルホニルセミカルバジド、カルボニルセミカルバジド、セミカルバジドおよび尿素、その薬学的組成物、ならびにアレナウイルスに関連する感染を含む、出血熱ウイルスを治療するための方法。

Country Status (10)

Country Link
US (3) US7994221B2 (cg-RX-API-DMAC7.html)
EP (1) EP2124921A4 (cg-RX-API-DMAC7.html)
JP (1) JP2010526025A (cg-RX-API-DMAC7.html)
KR (1) KR20100028017A (cg-RX-API-DMAC7.html)
CN (1) CN101641092A (cg-RX-API-DMAC7.html)
AU (1) AU2008257428A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0806920A2 (cg-RX-API-DMAC7.html)
CA (1) CA2674967A1 (cg-RX-API-DMAC7.html)
MX (1) MX2009007687A (cg-RX-API-DMAC7.html)
WO (1) WO2008147474A2 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8410149B2 (en) * 2004-12-06 2013-04-02 Siga Technologies Inc. Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
US7994221B2 (en) 2004-12-06 2011-08-09 Siga Technologies, Inc. Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
AU2005314252B2 (en) * 2004-12-06 2012-09-27 Siga Technologies, Inc. Compounds and methods for treating hemorrhagic fever viruses
US8791110B2 (en) 2006-02-01 2014-07-29 Siga Technologies, Inc. Anti-arenaviral compounds
EP1984379A4 (en) 2006-02-01 2011-05-18 Siga Technologies Inc ANTI-ARENAVIRAL COMPOUNDS
EP1988776B1 (en) 2006-03-02 2012-08-08 Siga Technologies, Inc. Antiviral drugs for treatment of arenavirus infection
US7977365B2 (en) 2006-03-02 2011-07-12 Siga Technologies, Inc. Antiviral drugs for treatment of arenavirus infection
US8871746B2 (en) 2006-03-02 2014-10-28 Kineta Four, LLC Antiviral drugs for treatment of arenavirus infection
EP1988884A4 (en) 2006-03-02 2009-09-30 Siga Technologies Inc ANTIVIRAL DRUGS FOR THE TREATMENT OF ARENAVIRUS INFECTIONS
JP2010528051A (ja) 2007-05-23 2010-08-19 シガ・テクノロジーズ・インコーポレーテッド デング感染症の治療または予防のための抗ウイルス薬
US20120207620A1 (en) 2007-07-12 2012-08-16 Odyne Systems, LLC. Hybrid vehicle drive system and method and idle reduction system and method
US8978798B2 (en) 2007-10-12 2015-03-17 Odyne Systems, Llc Hybrid vehicle drive system and method and idle reduction system and method
US9061680B2 (en) 2007-07-12 2015-06-23 Odyne Systems, Llc Hybrid vehicle drive system and method for fuel reduction during idle
US8408341B2 (en) 2007-07-12 2013-04-02 Odyne Systems, Llc Hybrid vehicle drive system and method and idle reduction system and method
US9283954B2 (en) 2007-07-12 2016-03-15 Odyne Systems, Llc System for and method of fuel optimization in a hybrid vehicle
US9878616B2 (en) 2007-07-12 2018-01-30 Power Technology Holdings Llc Hybrid vehicle drive system and method using split shaft power take off
US8818588B2 (en) 2007-07-12 2014-08-26 Odyne Systems, Llc Parallel hybrid drive system utilizing power take off connection as transfer for a secondary energy source
CN101801189B (zh) 2007-08-27 2015-08-26 基内塔第四有限责任公司 用于治疗沙粒病毒感染的抗病毒药
WO2013022550A2 (en) * 2011-08-10 2013-02-14 President And Fellows Of Harvard College Small molecule inhibitors of ebola and lassa fever viruses
US12330657B2 (en) 2011-12-02 2025-06-17 Power Technology Holdings Llc Hybrid vehicle drive system and method for fuel reduction during idle
US11225240B2 (en) 2011-12-02 2022-01-18 Power Technology Holdings, Llc Hybrid vehicle drive system and method for fuel reduction during idle
EP3071438A4 (en) 2013-11-18 2017-08-02 Power Technology Holdings LLC Hybrid vehicle drive system and method using split shaft power take off
DE102015207036A1 (de) * 2015-04-17 2016-10-20 Karl Sebastian Lang Arenaviren zur Anwendung bei der Behandlung und/oder Vorbeugung von Tumoren sowie Verfahren zur Herstellung von Arenaviren mit (verbesserten) tumorregressiven Eigenschaften
US11629139B2 (en) 2017-09-08 2023-04-18 President And Fellows Of Harvard College Small molecule inhibitors of Ebola and Lassa fever viruses and methods of use
CN117582436A (zh) * 2023-08-31 2024-02-23 甫康(上海)健康科技有限责任公司 亚胺酰基酰肼类化合物、含其的组合物和其应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3709574A1 (de) 1987-03-24 1988-10-06 Bayer Ag Substituierte triazolinone
US5625073A (en) 1987-06-12 1997-04-29 Bayer Aktiengesellschaft Herbicidal substituted triazolinones
DE3803523A1 (de) 1987-06-12 1988-12-22 Bayer Ag Substituierte triazolinone
US5182303A (en) 1988-12-27 1993-01-26 E. I. Du Pont De Nemours And Company Substituted semicarbazone arthropodicides
DE3916208A1 (de) 1989-05-18 1990-11-22 Bayer Ag Substituierte triazolone
US5194084A (en) 1989-05-18 1993-03-16 Bayer Aktiengesellschaft Herbicidal substituted triazolones
US5534486A (en) 1991-04-04 1996-07-09 Bayer Aktiengesellschaft Herbicidal sulphonylaminocarbonyl triazolinones having substituents bonded via oxygen
DE4111394A1 (de) 1991-04-09 1992-10-15 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel
WO1995033719A1 (en) 1994-06-02 1995-12-14 Zeneca Limited Substituted pyrrolidone, thiazolidones or oxazolidones as herbicides
US5814442A (en) 1994-06-10 1998-09-29 Georgetown University Internally controlled virion nucleic acid amplification reaction for quantitation of virion and virion nucleic acid
US6610683B2 (en) 1996-09-12 2003-08-26 Idun Pharmaceuticals, Inc. Treatment of infectious disease using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
US5945446A (en) 1997-02-10 1999-08-31 Laubc Biochemicals, Corporation Process for preparing synthetic soil-extract materials and medicaments based thereon
US6524567B2 (en) 1997-02-10 2003-02-25 Laub Biochemicals Corp. Synthetic soil-extract materials and medicaments for hemorrhagic fever viruses based thereon
US5904857A (en) 1997-04-17 1999-05-18 Nalco Chemical Company 4-alkyl and aryl semicarbazides as oxygen scavengers
AU1361499A (en) 1997-10-21 1999-05-10 Merck & Co., Inc. Azapeptide acids as cell adhesion inhibitors
JPH11240859A (ja) * 1997-12-26 1999-09-07 Nippon Bayer Agrochem Co Ltd フルオロ置換ベンゾイルウレア類及び有害生物防除剤
JP2002541215A (ja) 1999-04-09 2002-12-03 ユーロ−セルティック エス. ア. ナトリウムチャネル遮断薬組成物およびその使用
US7244721B2 (en) 2000-07-21 2007-07-17 Schering Corporation Peptides as NS3-serine protease inhibitors of hepatitis C virus
US7335779B2 (en) 2002-03-08 2008-02-26 Quonova, Llc Modulation of pathogenicity
US20040077607A1 (en) 2002-10-21 2004-04-22 Uckun Fatih M. Aryl phosphate derivatives of d4T with potent anti-viral activity against hemorrhagic fever viruses
WO2004096197A2 (en) 2003-05-02 2004-11-11 Universita Degli Studi Di Cagliari 5-aza-7-deazapurine nucleosides for treating flaviviridae
CA2529761C (en) 2003-06-20 2013-08-13 Siga Technologies, Inc. Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases
US7687641B2 (en) 2003-06-20 2010-03-30 Siga Technologies, Inc. Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
US7737168B2 (en) 2003-06-20 2010-06-15 Siga Technologies, Inc. Compounds, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
DE10348023A1 (de) 2003-10-15 2005-05-19 Imtm Gmbh Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
AU2005314252B2 (en) 2004-12-06 2012-09-27 Siga Technologies, Inc. Compounds and methods for treating hemorrhagic fever viruses
US7994221B2 (en) * 2004-12-06 2011-08-09 Siga Technologies, Inc. Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
EP1984379A4 (en) 2006-02-01 2011-05-18 Siga Technologies Inc ANTI-ARENAVIRAL COMPOUNDS
EP1988776B1 (en) 2006-03-02 2012-08-08 Siga Technologies, Inc. Antiviral drugs for treatment of arenavirus infection
EP1988884A4 (en) 2006-03-02 2009-09-30 Siga Technologies Inc ANTIVIRAL DRUGS FOR THE TREATMENT OF ARENAVIRUS INFECTIONS
US7977365B2 (en) 2006-03-02 2011-07-12 Siga Technologies, Inc. Antiviral drugs for treatment of arenavirus infection
CN104758281A (zh) 2007-04-23 2015-07-08 西佳技术公司 用于治疗和预防正痘病毒感染和相关疾病的化合物、组合物和方法
JP2010528051A (ja) 2007-05-23 2010-08-19 シガ・テクノロジーズ・インコーポレーテッド デング感染症の治療または予防のための抗ウイルス薬
CN101801189B (zh) 2007-08-27 2015-08-26 基内塔第四有限责任公司 用于治疗沙粒病毒感染的抗病毒药
BRPI0905388A2 (pt) 2008-01-15 2015-10-13 Siga Technologies Inc "composição farmacêutica; compostos e métodos de tratamento de infecção por arenavirus"
WO2009149054A1 (en) 2008-06-03 2009-12-10 Siga Technologies, Inc. Small molecule inhibitors for the treatment or prevention of dengue virus infection
WO2012060820A1 (en) 2010-11-02 2012-05-10 Siga Technologies, Inc. Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses

Similar Documents

Publication Publication Date Title
JP2010526025A5 (cg-RX-API-DMAC7.html)
JP2009501198A5 (cg-RX-API-DMAC7.html)
JP2010536766A5 (cg-RX-API-DMAC7.html)
JP2012506896A5 (cg-RX-API-DMAC7.html)
JP2009543795A5 (cg-RX-API-DMAC7.html)
JP2011529502A5 (cg-RX-API-DMAC7.html)
JP2014502979A5 (cg-RX-API-DMAC7.html)
JP2005511547A5 (cg-RX-API-DMAC7.html)
JP2011513410A5 (cg-RX-API-DMAC7.html)
JP2013517322A5 (cg-RX-API-DMAC7.html)
RU2015101210A (ru) Производные тиофена, используемые для лечения сахарного диабета
JP2009543794A5 (cg-RX-API-DMAC7.html)
JP2020505354A5 (cg-RX-API-DMAC7.html)
JP2012511558A5 (cg-RX-API-DMAC7.html)
JP2013513607A5 (cg-RX-API-DMAC7.html)
JP2012518648A5 (cg-RX-API-DMAC7.html)
JP2005510457A5 (cg-RX-API-DMAC7.html)
JP2010535706A5 (cg-RX-API-DMAC7.html)
JP2010534246A5 (cg-RX-API-DMAC7.html)
JP2011528662A5 (cg-RX-API-DMAC7.html)
JP2011524362A5 (cg-RX-API-DMAC7.html)
JP2010535751A5 (cg-RX-API-DMAC7.html)
RU2008129641A (ru) Ингибиторы ccr9 активности
JP2010526051A5 (cg-RX-API-DMAC7.html)
JP2008520594A5 (cg-RX-API-DMAC7.html)